MedPath

Evaluation of Maxillary and Mandibulary Nerve Blocks on Morphine Consumption

Completed
Conditions
Dento Facial Dysmorphism
Interventions
Procedure: Maxillary and mandibular blocks
Procedure: General anesthesia
Registration Number
NCT03299998
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

Background and Objectives: Double-jaw surgery is one of the most painful oral surgery, requiring multimodal analgesia including controlled morphine pump and its secondary effects. The aim of this study was to evaluate the effectiveness of face block (mandibulary and maxillary block analgesia) on the first 24 hours on morphine consumption in patients admitted for double jaw surgery.

Detailed Description

Methods: Patients undergoing double-jaw surgery between January 2015 and May 2017 were enrolled. Patients were separated into 2 groups: patients receiving maxillary-mandibulary nerve block and those no receiving it. The primary endpoint was the morphine consumption within 24 hours post-surgery. Secondary endpoints were the intra-operative remifentanil consumption, incidence of postoperative nausea and vomiting at 24 hours, morphine consumption in recovery room, length of stay in hospital.

Recruitment & Eligibility

Status
COMPLETED
Sex
Not specified
Target Recruitment
92
Inclusion Criteria
  • Male and female who underwent double jaw surgery
Read More
Exclusion Criteria
  • opposition to the study
  • an additional surgical procedure
  • preoperative consumption of morphine or derived from morphine
  • perioperative N20
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
BLOCK+General anesthesiaPatients who underwent maxillary and mandibulary block before surgery
BLOCK -General anesthesiaPatients who did not undergo maxillary and mandibulary block before surgery.
BLOCK+Maxillary and mandibular blocksPatients who underwent maxillary and mandibulary block before surgery
Primary Outcome Measures
NameTimeMethod
Cumulative morphine consumption within 24 hours post-surgery24 hours

Cumulative morphine consumption measured using patient controlled analgesia (PCA-pump).

Secondary Outcome Measures
NameTimeMethod
Peroperative remifentanil consumptionEnd of surgery (2 hours in average)

Remifentanil consumption in µg.kg-1 during surgery

Cumulative morphine consumption within 12 hours post-surgery12 hours

Cumulative morphine consumption measured using patient controlled analgesia (PCA-pump).

Hospital length of stayUp to hospital discharge (5 days in average)

Delay between hospitalization date and date of hospital discharge

Cumulative morphine consumption within 48 hours post-surgery48 hours

Cumulative morphine consumption measured using patient controlled analgesia (PCA-pump).

Trial Locations

Locations (1)

Hospices Civils de Lyon

🇫🇷

Lyon, France

© Copyright 2025. All Rights Reserved by MedPath